At BIO, San Diego touts its genomics breadth

The annual BIO meeting brings out economic development authorities from across the US and around the world, all pitching their locales as the preferred place to site a new lab or biotech manufacturing facility. This year, host city San Diego […]

Read More

Getting ready for MACRA

Providing meaningful real-world evidence (RWE) to providers—to enable them to better manage healthcare services—will be a growing part of the life sciences industry’s marketing activity in coming years, according to stakeholders convened by the Network for Excellence in Health Innovation, […]

Read More

A Conversation with John Chiminski, Catalent

In April, Catalent, Inc., celebrated its 10th anniversary of its inception, having been spun out of Cardinal Health in 2007 and acquired by Blackstone Group, a private-equity firm. Later, in 2014, the company went public, traded on the NYSE. Both […]

Read More

INC Research and Inventiv Health to merge

The No. 7 (by revenue) contract research organization, INC Research, and the No. 6 CRO, inVentiv Health, are merging, creating what the company managements expect will be the No. 3 CRO, plus, by virtue of inVentiv’s “contract commercial organization,” a […]

Read More